OBJECTIVE: Whole-body protein metabolism is abnormal in suboptimally controlled type 2 diabetes and obesity. We hypothesized that glycemia, insulin resistance, and waist circumference modulate these alterations in type 2 diabetes and, to a lesser extent, in individuals without type 2 diabetes. RESEARCH DESIGN AND METHODS: In 88 lean and obese subjects without and 40 with type 2 diabetes on an inpatient protein-controlled isoenergetic diet for 7 days, whole-body protein turnover was measured using the fed-fasted 60-h oral (15)N-glycine method. Nitrogen flux was determined from urinary (15)N urea and protein synthesis, breakdown and net balance calculated. Indexes of diabetes control, resting energy expenditure (REE), and body composition were assessed. RESULTS: Higher protein turnover in obese subjects was further increased, and net balance was lower in type 2 diabetes. Waist-to-hip ratio and ln homeostasis model assessment of insulin resistance (HOMA-IR) explained 40% of the variance in flux in type 2 diabetes; fat-free mass and lnHOMA-IR explained 62% in subjects without type 2 diabetes. Overall, fasting glucose explained 16% of the variance in net balance. In type 2 diabetes, net balance correlated negatively with fasting glucose in men and positively with hip circumference in women. CONCLUSIONS: Kinetics of whole-body protein metabolism are elevated, and net balance is diminished in type 2 diabetes, independently of obesity. Elevated flux is associated with greater visceral adiposity, REE, and insulin resistance of glucose. In type 2 diabetic men, these alterations worsened with magnitude of hyperglycemia. In type 2 diabetic women, larger hip circumferences may protect against such alterations. Our findings suggest that dietary protein requirements may be greater in type 2 diabetes to offset a reduced net balance, aggravated as glycemia increases, especially in men.
OBJECTIVE: Whole-body protein metabolism is abnormal in suboptimally controlled type 2 diabetes and obesity. We hypothesized that glycemia, insulin resistance, and waist circumference modulate these alterations in type 2 diabetes and, to a lesser extent, in individuals without type 2 diabetes. RESEARCH DESIGN AND METHODS: In 88 lean and obese subjects without and 40 with type 2 diabetes on an inpatient protein-controlled isoenergetic diet for 7 days, whole-body protein turnover was measured using the fed-fasted 60-h oral (15)N-glycine method. Nitrogen flux was determined from urinary (15)N urea and protein synthesis, breakdown and net balance calculated. Indexes of diabetes control, resting energy expenditure (REE), and body composition were assessed. RESULTS: Higher protein turnover in obese subjects was further increased, and net balance was lower in type 2 diabetes. Waist-to-hip ratio and ln homeostasis model assessment of insulin resistance (HOMA-IR) explained 40% of the variance in flux in type 2 diabetes; fat-free mass and lnHOMA-IR explained 62% in subjects without type 2 diabetes. Overall, fasting glucose explained 16% of the variance in net balance. In type 2 diabetes, net balance correlated negatively with fasting glucose in men and positively with hip circumference in women. CONCLUSIONS: Kinetics of whole-body protein metabolism are elevated, and net balance is diminished in type 2 diabetes, independently of obesity. Elevated flux is associated with greater visceral adiposity, REE, and insulin resistance of glucose. In type 2 diabeticmen, these alterations worsened with magnitude of hyperglycemia. In type 2 diabeticwomen, larger hip circumferences may protect against such alterations. Our findings suggest that dietary protein requirements may be greater in type 2 diabetes to offset a reduced net balance, aggravated as glycemia increases, especially in men.
Authors: Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn Journal: Metabolism Date: 2010-04-27 Impact factor: 8.694
Authors: P L Wander; E J Boyko; D L Leonetti; M J McNeely; S E Kahn; W Y Fujimoto Journal: Diabetes Res Clin Pract Date: 2011-02-01 Impact factor: 5.602
Authors: Kevin R Short; Brian A Irving; Ananda Basu; C Michael Johnson; K Sreekumaran Nair; Rita Basu Journal: J Clin Endocrinol Metab Date: 2012-10-02 Impact factor: 5.958
Authors: Carrie A Karvonen-Gutierrez; Qing Peng; Mark Peterson; Kate Duchowny; Bin Nan; Sioban Harlow Journal: Age Ageing Date: 2018-09-01 Impact factor: 10.668
Authors: Olasunkanmi A J Adegoke; Stéphanie Chevalier; José A Morais; Réjeanne Gougeon; Scot R Kimball; Leonard S Jefferson; Simon S Wing; Errol B Marliss Journal: Am J Physiol Endocrinol Metab Date: 2008-10-28 Impact factor: 4.310
Authors: Anna Coppola; Brett R Wenner; Olga Ilkayeva; Robert D Stevens; Mauro Maggioni; Theodore A Slotkin; Edward D Levin; Christopher B Newgard Journal: Am J Physiol Endocrinol Metab Date: 2012-12-18 Impact factor: 4.310
Authors: Seok Won Park; Bret H Goodpaster; Jung Sun Lee; Lewis H Kuller; Robert Boudreau; Nathalie de Rekeneire; Tamara B Harris; Stephen Kritchevsky; Frances A Tylavsky; Michael Nevitt; Yong-wook Cho; Anne B Newman Journal: Diabetes Care Date: 2009-06-23 Impact factor: 19.112